---
title: "Noble Explochem Ltd (506991) — Share Price, Financials & Analysis"
symbol: "506991"
company: "Noble Explochem Ltd"
canonical: "https://tapetide.com/stocks/506991"
isin: "INE875D01011"
bse_code: "506991"
sector: "Commodities"
industry: "Chemicals & Petrochemicals"
generated_at: "2026-09-13T18:49:21.727Z"
---

# Noble Explochem Ltd (506991)

Canonical page: https://tapetide.com/stocks/506991

## Company

- **BSE Code:** 506991
- **ISIN:** INE875D01011
- **Sector:** Commodities
- **Industry:** Chemicals & Petrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2006-03-01
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** neclindia.com

## About

Noble Explochem is principally engaged in the production of explosives. The Company manufactures emulsion-based explosives and petrochemicals.

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- Contingent liabilities of Rs.26.3 Cr.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -97% | -22% | 0% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.38 | 0.08 | 0.13 | 0.12 | 0.26 | 0.18 | 0.17 | 0.25 | 0.6 | 0.23 | 0.24 | 0.4 |
| Operating Profit | -0.38 | -0.08 | -0.13 | -0.12 | -0.26 | -0.18 | -0.17 | -0.25 | -0.6 | -0.23 | -0.24 | -0.4 |
| Other Income | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0.15 | 0.07 | 0 | 0.01 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.34 | -0.08 | -0.13 | -0.12 | -0.26 | -0.18 | -0.17 | -0.1 | -0.53 | -0.23 | -0.24 | -0.4 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0.34 | -0.08 | -0.13 | -0.12 | -0.26 | -0.18 | -0.17 | -0.1 | -0.53 | -0.23 | -0.24 | -0.4 |
| EPS in Rs | -0.18 | -0.04 | -0.07 | -0.06 | -0.14 | -0.09 | -0.09 | -0.05 | -0.28 | -0.12 | -0.12 | -0.21 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 13.62 | 0.99 | 0.89 | 0.84 | 0.82 | 0.84 | 0.91 | 0.59 | 1.2 | 1.47 |
| Operating Profit | -13.62 | -0.99 | -0.89 | -0.84 | -0.82 | -0.84 | -0.91 | -0.59 | -1.2 | -1.47 |
| OPM % | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0.01 | 0.02 | 0.24 | 0.09 | 0 | 0.23 | 0.04 | 0.04 | 0.22 | 0.08 |
| Interest | 0 | 0.04 | 0.11 | 0.25 | 0.01 | 0.03 | 0 | 0 | 0 | 0.01 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -13.61 | -1.01 | -0.76 | -1 | -0.83 | -0.64 | -0.87 | -0.55 | -0.98 | -1.4 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Net Profit | -13.61 | -1.01 | -0.76 | -1 | -0.83 | -0.64 | -0.87 | -0.55 | -0.98 | -1.4 |
| EPS in Rs | -7.08 | -0.53 | -0.4 | -0.52 | -0.43 | -0.33 | -0.45 | -0.29 | -0.51 | -0.73 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 |
| Reserves | -33.31 | -46.72 | -46.73 | -45.42 | -44.11 | -44.48 | -44.96 | -45.8 | -46.35 | -47.33 |
| Borrowings | 35.05 | 35.07 | 35.09 | 34.94 | 33.69 | 34.12 | 34.1 | 34.45 | 34.95 | 35.02 |
| Other Liabilities | 12.33 | 12.52 | 12.44 | 11.44 | 11.57 | 11.4 | 11.72 | 12.01 | 12.15 | 12.99 |
| Total Liabilities | 33.28 | 20.08 | 20.01 | 20.17 | 20.36 | 20.25 | 20.07 | 19.87 | 19.96 | 19.89 |
| Fixed Assets | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.7 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 14.45 | 1.25 | 1.18 | 1.34 | 1.53 | 1.47 | 1.29 | 1.09 | 1.18 | 1.19 |
| Total Assets | 33.28 | 20.08 | 20.01 | 20.17 | 20.36 | 20.25 | 20.07 | 19.87 | 19.96 | 19.89 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | -0.23 | -1.08 | -1.95 | -2.26 | -1 | -0.33 | -0.56 | -0.45 | -0.18 |
| Cash from Investing Activity | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 | 0.09 |
| Cash from Financing Activity | — | 0.22 | 1.07 | 2.07 | 2.37 | 1.02 | 0.14 | 0.38 | 0.5 | 0.07 |
| Net Cash Flow | — | -0.01 | -0.01 | 0.12 | 0.11 | 0.01 | -0.19 | -0.18 | 0.04 | -0.03 |
| Free Cash Flow | — | -0.23 | -1.08 | -1.95 | -2.26 | -1 | -0.33 | -0.56 | -0.46 | -0.09 |
| CFO/OP | — | 2 | 109 | 219 | 269 | 122 | 39 | 62 | 76 | 15 |

### Ratios

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | — | — | — | — | — | — | — | — | — | — |
| Inventory Days | — | — | — | — | — | — | — | — | — | — |
| Days Payable | — | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | — | — | — | — | — | — | — | — | — | — |
| Working Capital Days | — | — | — | — | — | — | — | — | — | — |
| ROCE % | 7.61 | -95.48 | -12.82 | -7.98 | -8.56 | -9.3 | -7.09 | -10.73 | -7.02 | -13.32 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Sep 2019 |
| --- | --- | --- | --- | --- |
| Promoters | 12.98% | 13.08% | 13.08% | 13.08% |
| Public | 87.02% | 86.92% | 86.92% | 86.92% |
| No. of Shareholders | 11543 | 11384 | 11278 | 11295 |

### Quarterly

| Category | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 12.98% | 12.98% | 12.98% | 13.08% | 13.08% | 13.08% | 13.08% | 13.08% | 14.63% | 13.08% | 13.08% | 13.08% |
| Public | 87.02% | 87.02% | 87.02% | 86.92% | 86.92% | 86.92% | 86.92% | 86.92% | 85.37% | 86.92% | 86.92% | 86.92% |
| No. of Shareholders | 11656 | 11543 | 11474 | 11427 | 11375 | 11384 | 11243 | 11249 | 10751 | 11278 | 11286 | 11295 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 6 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 161.48 | Buy |
| EMA (10) | 162.32 | Buy |
| SMA (20) | 168.46 | Sell |
| EMA (20) | 166.01 | Sell |
| SMA (50) | 173.98 | Sell |
| EMA (50) | 172.57 | Sell |
| SMA (100) | 182.85 | Sell |
| EMA (100) | 177.54 | Sell |
| SMA (200) | 180.78 | Sell |
| EMA (200) | 181.21 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.7 | Neutral |
| MACD (12,26,9) | -4.54 | Sell |
| Stochastic (14,3,3) | 33.75 | Neutral |
| ADX (14) | 26.67 | Buy |
| Williams %R (14) | -49.9 | Neutral |
| ATR (14) | 6.77 | High Volatility |
| ROC (12) | -4.24 | Sell |
| Stoch RSI (14) | 79.08 | Neutral |
| UO (7,14,28) | 52.96 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Jan 2020 - Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December 2019. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Jan 2020 - Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December 2019.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0cf3c56-5475-4de2-b8b2-565b8024753c.pdf) |
| 9 Jan 2020 - Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December 2019. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Jan 2020 - Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December 2019.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a0cf3c56-5475-4de2-b8b2-565b8024753c.pdf) |
| 23 Jan 2020 - Hon''ble NCLT, Mumbai Bench has approved the Resolution Plan submitted by IPCA Laboratories Limited for Noble Explochem Limited vide order dated 22nd January 2020. | [Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal 23 Jan 2020 - Hon''ble NCLT, Mumbai Bench has approved the Resolution Plan submitted by IPCA Laboratories Limited for Noble Explochem Limited vide order dated 22nd January 2020.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4411da4d-e22e-4b6f-96ba-b6751e68162e.pdf) |
| 23 Jan 2020 - Hon''ble NCLT, Mumbai Bench has approved the Resolution Plan submitted by IPCA Laboratories Limited for Noble Explochem Limited vide order dated 22nd January 2020. | [Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal 23 Jan 2020 - Hon''ble NCLT, Mumbai Bench has approved the Resolution Plan submitted by IPCA Laboratories Limited for Noble Explochem Limited vide order dated 22nd January 2020.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4411da4d-e22e-4b6f-96ba-b6751e68162e.pdf) |
| 14 Nov 2025 - Unaudited standalone results for half year ended Sep 30, 2025 with limited review report filed. | [Unaudited Standalone Financial Results For The Half Year Ended September 30, 2025 Along With The Limited Review Report. 14 Nov 2025 - Unaudited standalone results for half year ended Sep 30, 2025 with limited review report filed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0dc5c639-79d2-427c-8d37-8d742cd396fe.pdf) |
| 14 Nov 2025 - Unaudited standalone results for half year ended 30 Sep 2025; limited review report submitted 14 Nov 2025. | [Intimation Of Unaudited Standalone Financial Results For The Half Year Ended September 30, 2025 Along With The Limited Review Report 14 Nov 2025 - Unaudited standalone results for half year ended 30 Sep 2025; limited review report submitted 14 Nov 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ed2af990-f8f1-42ef-a4df-457bc9534834.pdf) |
| 14 Nov 2025 - IPO funds deviation statement filed as on Sep 30, 2025 for Broach Lifecare (Scrip 544231) | [Statement Of Deviation(S) Or Variation(S) Of Funds Raised Through Public Issue 14 Nov 2025 - IPO funds deviation statement filed as on Sep 30, 2025 for Broach Lifecare (Scrip 544231)](https://www.bseindia.com/xml-data/corpfiling/AttachHis/85af7f87-3b61-4461-977c-580902a19bb6.pdf) |
| 14 Nov 2025 - Board appointed M/s. R. M. Hariyani & Co. as internal auditor for FY2025-26 on November 14, 2025. | [Intimation For Appointment Of Internal Auditor For FY 2025-26 14 Nov 2025 - Board appointed M/s. R. M. Hariyani & Co. as internal auditor for FY2025-26 on November 14, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f97a334b-d02d-4f44-baa2-9d74ac21a416.pdf) |
| 14 Nov 2025 - Appointed N R Shah and Co as Secretarial Auditor for FY2025-26 on 14 November 2025. | [Intimation For Appointment Of Secretarial Auditor For The FY 2025-26 14 Nov 2025 - Appointed N R Shah and Co as Secretarial Auditor for FY2025-26 on 14 November 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4453cd9a-cc23-4a36-bab4-241fe99cd4a7.pdf) |
| — | [Unaudited Financial Results For The Nine Months And Quarter Ended Dec 2019 19 Feb 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=178afa8d-6350-4fd6-95bd-f203ab76216e.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7e0caca3-602f-4515-8078-658772bf4dcc.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/506991/5069910319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/506991/5069910318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/506991/5069910317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/506991/5069910316.pdf) |
| from bse | [Annual Report 2015 from bse](https://www.bseindia.com/bseplus/AnnualReport/506991/5069910315.pdf) |
| from bse | [Annual Report 2014 from bse](https://www.bseindia.com/bseplus/AnnualReport/506991/5069910314.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:49:21.727Z.